Vimarsana
Biggest News Aggregation in the World

Page 21 - Roxana Mehran News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Roxana Mehran. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Roxana Mehran Today - Breaking & Trending Today

Heart disease is the leading cause of death for women. Researchers fear our health system isn't keeping up. - Vimarsana News

Heart disease is the leading cause of death for women. Researchers fear our health system isn't keeping up.

CBS News CBS News May 17, 2021, 11:01 AM Heart disease is the leading cause of death for women. Researchers fear our health system isn't keeping up. Heart disease is the leading cause of death for women globally. The report made a number of recommendations, including more education on early detection for health care providers and patients, recruiting more women for cardiac studies and prioritizing research on heart disease in women.  Doctors say strengthening the health care system's ability to detect these cardiovascular issues and building awareness of them could ...

The Lancet: Experts call for urgent action to reduce global burden of cardiovascular disease in women by 2030 - Vimarsana News

The Lancet: Experts call for urgent action to reduce global burden of cardiovascular disease in women by 2030

In the first-ever global report on cardiovascular disease (CVD) in women, researchers call for urgent action to improve care and prevention, fill knowledge gaps, and increase awareness to tackle the worldwide leading cause of death among women. The all female-led Commission report was published in The Lancet and presented during a plenary session at the American College of Cardiology's 70th Annual Scientific Session (ACC.21).

FFR Disappoints as Guide for PCI on Non-Culprit Lesions in STEMI - Vimarsana News

FFR Disappoints as Guide for PCI on Non-Culprit Lesions in STEMI

email article Hemodynamic assessment did not improve guidance for complete revascularization in multivessel stenting for patients with ST-segment elevation MI (STEMI), according to the FLOWER-MI trial. Fractional flow reserve (FFR) was no better than angiography at guiding percutaneous coronary intervention (PCI) on nonculprit lesions in terms of 1-year clinical outcomes among more than 1,000 study participants, reported Etienne Puymirat, of the European Hospital of Georges Pompidou in Paris. By then, the combined rate of all-cause mortality, MI, or unplanned hospitalization leading to ...

Socioeconomic Disparities Associate With Epigenetics and Heart Failure Outcomes - Vimarsana News

Socioeconomic Disparities Associate With Epigenetics and Heart Failure Outcomes

Previously, Wende’s group assisted in a study that identified links between DNA methylation in all cause heart failure associated with the ability to use different metabolic fuels to maintain contractility, namely a decrease in oxidative metabolism.[2] An additional study from the group found molecular mechanisms specific to ischemic heart failure, which identified a key epigenetic regulator (i.e. EZH2) as likely having an active role in gene expression regulation involved in both metabolic and structural remodeling.[3]  In the new study highlighted here, the research group and lead invest...

Dual Bests Triple Therapy in Nonvalvular AF Patients in RE-DUAL PCI - Vimarsana News

Dual Bests Triple Therapy in Nonvalvular AF Patients in RE-DUAL PCI

April 09, 2021 Dropping aspirin soon after PCI seems to be the best strategy for preventing bleeding in high-risk patients with nonvalvular atrial fibrillation (AF), according to a landmark analysis of the RE-DUAL PCI trial. As reported by TCTMD, RE-DUAL PCI supported moving away from a triple-therapy strategy—P2Y12 inhibitor, warfarin, and aspirin—in these patients in order to lessen bleeding without increasing the risk of thrombotic events. The new data in conjunction with the rest of the available evidence, including those from AUGUSTUS, “are pretty clear that that strategy of prolon...

Source: tctmd.com